THIS IS A SOURCES SOUGHT NOTICE to determine the availability and capability of small businesses (including certified 8(a), Small Disadvantaged, and HUBZone firms; veteran and service-disabled veteran-owned small businesses, and women-owned small businesses. This notice is for planning purposes only, and does not constitute an Invitation for Bids, a Request for Proposals, Solicitation, Request for Quotes, or an indication the Government will contract for the items contained herein. This notice is not to be construed as a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. The Government does not reimburse respondents for any cost associated with submission of the information being requested or reimburse expenses incurred to interested parties for responses to this sources sought. Any responses received will not be used as a proposal. Description of Services: Background: The Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR) staff engaged in research in bioinformatics, genomics, proteomics, and metabolomics require highly specialized software for biological pathway and molecular network analysis and biomarker discovery. Ingenuity Pathway Analysis (IPA) software is used throughout the FDA. NCTR holds two, one-concurrent licenses of IPA software and requires annual license renewal to continue to support the pathway analysis and molecular network research at NCTR and the regulatory science needs of the FDA. Objective Objective: Renewal of two existing, one-concurrent user licenses for Ingenuity Pathway Analysis Software and training. Scope Licenses for Ingenuity Pathway Analysis Software are required to continue to support the pathway analysis and molecular network research at NCTR and the regulatory science needs of the FDA. The FDA intends to award a Firm Fixed price contract to meet the requirements of this solicitation. Deliverables - Renewal of two existing, one-concurrent user licenses for Ingenuity Pathway Analysis Software - The licenses for the application must allow for creation of two user groups. The groups shall be independent (i.e., users from one group will not utilize the license for the other group) - The licenses must be concurrent and not tied to named users or computers - Onsite training: - The vendor shall provide one day of onsite training at the NCTR campus located in Jefferson, Arkansas - Training shall cover accessing and operating the software, including all major analytical functions and workflows, and include question and answer sessions - Vendor shall provide training materials for the class - The training shall be scheduled on a date mutually agreeable to the vendor and the NCTR point of contact - Training shall begin no later than 10:00 A.M. Central time, be completed no later than 4:00 P.M. Central time and span not less than 4 hours of actual instruction. A one hour break for lunch shall be provided - Onsite training shall be provided no later than 60 calendar days after award An example of a product that meets our needs is as follows: Item#1 #830076 IPA with Advanced Analytics 2 each Item#2 #830500One day on site IPA training of Performance: 1 each Place of Performance The licenses must be concurrent and not tied to named users or computers. License renewal may be delivered electronically, for use at: US Food and Drug Administration National Center for Toxicological Research 3900 NCTR Road Jefferson, AR 72079 Period of Performance: One year: August 22, 2015 - August 21, 2016; and on-site training for user groups no later than 60 calendar days after award Companies are encouraged to respond if they have the capability and capacity to provide the identified services with little or no disruption of services to the current users at the FDA. Interested small business potential offerors are encouraged to respond to this notice. However, be advised that generic capability statements are not sufficient for effective evaluation of respondents' capacity and capability to perform the specific work as required. Responses must directly demonstrate the company's capability, experience, and/or ability to marshal resources to effectively and efficiently perform each of the tasks described above at a sufficient level of detail to allow definitive numerical evaluation; and evidence that the contractor can satisfy the minimum requirements listed above wile in compliance with FAR 52.219-14 ("Limitations on Subcontracting"). Failure to definitively address each of these factors will result in a finding that respondent lacks capability to perform the work. Responses to this notice shall be limited to 15 pages, and must include: 1. Company name, mailing address, e-mail address, telephone and fax numbers, website address (if available), and the name, telephone number, and e-mail address of a point of contact having the authority and knowledge to clarify responses with Government representatives. 2. Name, title, telephone number, and e-mail addresses of individuals who can verify the demonstrated capabilities identified in the responses. 3. Business size for NAICS 334516 with size limitation standards of $6.5M and status, if qualified as an 8(a) firm (must be certified by the Small Business Administration (SBA), Small Disadvantaged Business (must be certified by SBA), Woman-Owned Small Business, HUBZone firm (must be certified by SBA), and/or Service-Disabled Veteran Owned Small Business (must be listed in the VetBiz Vendor Information Pages). 4. DUNS number, CAGE Code, Tax Identification Number (TIN), and company structure (Corporation, LLC, partnership, joint venture, etc). Companies also must be registered in the Central Contractor Registration (CCR) at www.ccr.gov to be considered as potential sources. 5.. If the company has a Government approved accounting system, please identify the agency that approved the system. Please submit copies of any documentation, such as letters or certificates to indicate the firm's status (see item #3 above). To the maximum extent possible, please submit non-proprietary information. Any proprietary information submitted should be identified as such and will be properly protected from disclosure. Interested offerors should submit their capability statement not exceeding fifteen (15) pages in length, excluding standard brochures. SUBMISSIONS ARE DUE no later than 4:00pm, Eastern Time, July 25, 2015. The capabilities response shall be e-mailed to:
[email protected]. All information received in response to this notice that is marked Proprietary will be handled accordingly. Responses to the notice will not be returned, nor there any ensuing discussions or debriefings of any responses. Information provided in response to this notice will be used to assess alternatives available for determining how to proceed in the acquisition process. This notice is part of Government Market Research, a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for or award a competitive contract. The FDA will use the information submitted in response to this notice at its discretion and will not provide comments to any submission; however, the content of any responses to this notice may be reflected in subsequent solicitation. FDA reserves the right to contact any respondent to this notice for the sole purpose of enhancing FDA's understanding of the notice submission. This announcement is Government market research, and may result in revisions in both its requirements and its acquisition strategy based on industry responses. It is emphasized that this is a notice for planning and information purposes only and is not be construed as a commitment by the government to enter into a contractual agreement, nor will the government pay for information solicited.